|
Volumn 103, Issue 2, 2008, Pages 114-121
|
Contrast agents for MRI
|
Author keywords
Molecular imaging; MRI; Nanoparticles; Therapy
|
Indexed keywords
CARBON NANOTUBE;
CROSS LINKED IRON OXIDE;
DEXTRAN;
DOXORUBICIN;
EPITOPE;
FLUOROCARBON;
FUMAGILLIN;
GADOLINIUM CHELATE;
GADOLINIUM PENTETATE;
IRON OXIDE;
LIPOSOME;
NANOPARTICLE;
NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;
PACLITAXEL;
QUANTUM DOT;
SUPERPARAMAGNETIC IRON OXIDE;
ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
ATHEROSCLEROSIS;
BIOCHEMISTRY;
CELL LABELING;
DIAGNOSTIC PROCEDURE;
DRUG DELIVERY SYSTEM;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMAN;
MOLECULAR IMAGING;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
RESTENOSIS;
REVIEW;
STEM CELL;
THROMBOEMBOLISM;
THROMBOSIS;
ANIMALS;
ATHEROSCLEROSIS;
BIOLOGICAL MARKERS;
CARDIOVASCULAR DISEASES;
CONTRAST MEDIA;
FIBRIN;
HUMANS;
MAGNETIC RESONANCE IMAGING;
NANOPARTICLES;
STAINING AND LABELING;
STEM CELLS;
|
EID: 40549113000
PISSN: 03008428
EISSN: None
Source Type: Journal
DOI: 10.1007/s00395-008-0711-6 Document Type: Review |
Times cited : (78)
|
References (33)
|